HAAS JASON (Chief Financial Officer) purchased 1.6% of their position (1K shares) of ODYSSEY THERAPEUTICS, INC. on the open market
Open‑market purchase worth $20.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/12/2026ACC: 0001193125-26-217600
Officer· Chief Financial Officer
Since May 2026
+1K
Net shares
Net buyer
$20.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1K
Price / share
$20.00
Trade value
$20K
% of position
1.6%
5/8/2026
61.91K→62.91K
Total
Net shares
+1K
Net value
$20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/8/2026 | P · Purchase | +1K | $20.00 | $20K | 1.6% | 61.91K | 62.91K |
| Total | +1K | $20K | ||||||
Derivative Transactions0
No derivative transactions reported